Key Highlights
OKLO shares gain momentum following DOE safety documentation approval for Groves facility.
Federal clearance propels Texas isotope reactor toward operational launch.
Pre-market trading shows OKLO climbing as Groves nears July 2026 target.
Groves facility progresses to final federal review phase following safety milestone.
Texas reactor project achieves crucial DOE hurdle on path to criticality.
Shares of Oklo (OKLO) climbed during pre-market hours following the announcement that federal regulators approved crucial safety documentation for the company’s Texas-based reactor facility. OKLO reached $54.90, representing a 4.92% increase, after finishing the previous session at $52.33 with a 0.82% decline. The upward movement came as Groves, the company’s isotope test reactor, advanced closer to its final operational readiness phase.
Federal Safety Clearance Propels Groves Forward
Oklo announced that the Department of Energy granted approval for the Documented Safety Analysis associated with its Groves Isotope Test Reactor facility. This authorization arrived through the DOE’s Reactor Pilot Program, an initiative designed to accelerate select advanced nuclear reactor developments. The clearance marks the completion of a crucial safety documentation phase for the project.
The Documented Safety Analysis establishes comprehensive safety requirements for the reactor’s operation. This documentation examines all possible operational risks, outlines necessary safety measures, and defines protocols required before the facility can begin operations. The approval builds upon earlier DOE authorization of preliminary safety assessments conducted during the design and construction phases.
Having obtained both critical approvals, Groves has now progressed into the DOE’s ultimate pre-operational phase. What remains includes a comprehensive readiness assessment and final startup authorization from federal officials. Once granted, Oklo will be permitted to receive nuclear fuel, complete the loading process, and commence startup testing procedures.
Groves Facility Progresses Toward Mid-2026 Launch
The company is aiming for initial criticality at the Groves facility by July 2026. Reaching criticality represents the stage where a nuclear reactor successfully establishes and maintains a controlled, self-sustaining fission reaction. The upcoming review procedures will shape the timeline toward achieving this crucial benchmark.
Construction at the site commenced less than twelve months ago. Oklo positions Groves as a commercially oriented testing facility developed outside traditional national laboratory settings. The initiative utilizes privately held property, commercial-grade nuclear fuel supplies, and private-sector infrastructure while operating under federal supervision.
The Groves project also advances Oklo’s broader isotope production strategy. The facility is designed to help manufacture essential isotopes utilized across cancer treatment, industrial manufacturing, scientific research, aerospace applications, and national security operations. Currently, many of these isotopes rely on foreign suppliers or aging domestic production facilities.
Company Establishes U.S. Isotope Production Capability
The company anticipates that Groves will serve as a testing ground for production methodologies before scaling to larger commercial operations. The pilot facility will also enable performance evaluation and operational refinement of reactor systems. These efforts could strengthen domestic isotope manufacturing capacity and reduce foreign dependency.
Oklo specializes in fast fission power plant technology, nuclear fuel reprocessing solutions, and isotope manufacturing systems. The company previously obtained a site use authorization from the DOE for a commercial advanced fission facility. Additionally, Oklo secured nuclear fuel materials from Idaho National Laboratory to support its developmental efforts.
Oklo presents the Groves project as a demonstration of accelerated advanced nuclear deployment timelines. While the facility remains under DOE regulatory oversight pending fuel loading and criticality authorization, the recent approval provides a defined pathway toward operational launch.





